US Broker Ratings

Veracyte, Inc. (VCYT) Stock Analysis: Exploring the Impressive 32% Potential Upside for Investors

Veracyte, Inc. (VCYT) stands at the forefront of the healthcare sector, particularly within the diagnostics and research industry. Headquartered in South San Francisco, California, this innovative company specializes in genomic..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 48% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices sector, is capturing investor attention with its robust suite of hospital technology solutions and an appealing potential upside of..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking the 319.75% Potential Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a promising player in the biotechnology sector, has been catching the eye of investors with its innovative approach to cancer and infectious disease treatments. With a..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 45% Potential Upside for Biotech Investors

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), headquartered in Burnaby, Canada, is a biotechnology company making significant strides in the healthcare sector. Specializing in the neuroscience field, Xenon is focused on developing..

ICU Medical, Inc. (ICUI) Investor Outlook: A Closer Look at Potential 43.54% Stock Upside

For investors with a keen eye on the healthcare sector, ICU Medical, Inc. (NASDAQ: ICUI) presents an intriguing opportunity. Specializing in medical instruments and supplies, ICU Medical is poised at..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Analyzing a 58.63% Potential Upside in Biotechnology

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with its innovative focus on the development of medicines targeting serious diseases influenced by protein growth factors...

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating the Biotech Landscape with a 133.70% Revenue Growth

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is carving a niche for itself within the biotech sector, focusing on the development and commercialization of therapies targeting rare diseases and cancer. With a..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: A 162% Potential Upside with Strong Buy Ratings

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, has captured investor attention with its ambitious pipeline of novel biologics targeting a range of inflammatory and immunology..

Envista Holdings Corporation (NVST): Investor Outlook and Valuation Insights with 3.11% Potential Upside

Envista Holdings Corporation (NYSE: NVST) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista develops, manufactures, markets, and..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Unveiling a 69% Potential Upside with Robust Growth Prospects

Catalyst Pharmaceuticals, Inc. (CPRX), a dynamic player in the biotechnology sector, is capturing investor attention with its promising growth trajectory. With a market capitalization of $2.48 billion, this Coral Gables,..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 158% Potential Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT) stands out in the biotech sector with a compelling investment narrative driven by its clinical-stage focus on developing monoclonal antibodies for autoimmune diseases. Founded in 2018..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Potential 44.9% Upside in the Biotech Sector

MoonLake Immunotherapeutics (NASDAQ: MLTX) is carving a niche in the biotechnology sector, specifically in the treatment of inflammatory skin and joint diseases. As a clinical-stage company, MoonLake is dedicated to..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Uncovering a 37.98% Potential Upside in Biotechnology

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of novel therapeutic compounds aimed at addressing diseases with high..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a 112% Potential Upside in Biotech

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been catching the eyes of investors in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $4.73 billion, this U.S.-based..

Arcellx, Inc. (ACLX) Stock Analysis: Uncovering a 57% Upside Potential in the Biotech Sector

For investors keen on the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) offers a compelling opportunity, backed by robust analyst endorsements and significant potential upside. Headquartered in Redwood City, California, Arcellx..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Biotechnology Pioneer with an 83% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector, promising significant growth potential for investors willing to navigate the complexities of pharmaceutical innovation. With a market capitalization of $4.63..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook on a Biotech with 15% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention as it positions itself at the forefront of the biotechnology sector. Specializing in treatments for rare neuroendocrine diseases, the company is..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring 39.65% Potential Upside in Healthcare Innovation

Waystar Holding Corp. (NASDAQ: WAY), a dynamic player in the healthcare information services sector, is drawing significant attention from investors due to its promising growth trajectory and an attractive 39.65%..

Bausch + Lomb (BLCO) Stock Analysis: Navigating Eye Health with a 4% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO) is a key player in the healthcare sector, operating within the medical instruments and supplies industry. With a substantial market capitalization of $5.15 billion,..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring the 27.93% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, specifically within the health information services industry, has been drawing increasing attention from investors due to its impressive..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds